The Hindu Business Line : Merven Drug shareholders okay pref allotment

THE shareholders of Merven Drug Products Ltd (MDPL), the Hyderabad-based pharma company, at their extraordinary general meeting (EGM) held here on Tuesday have approved preferential allotment to various investors.

The members have approved preferential issue of 2.4-lakh and 40,000 equity shares of the face value of Rs 10 each at a premium of Rs 80 per share to SARA Fund Trustee Company Ltd and to The Trustees of IVC Employees Welfare Trust respectively.

The shareholders also okayed a proposal to offer 3-lakh equity shares of the face value of Rs 10 each at a premium of Rs 102.50 per share to the promoters and directors of the company.

Further, a proposal for preferential issue of 1,58,40,000 optionally unsecured fully convertible debentures of Rs 10 each at par convertible into 17,60,000 equity shares of the face value of Rs 10 each at a premium of Rs 80 per share against debentures in Arch Pharmachem Ltd held by IL&FS Trust Company Ltd, was okayed the company informed the stock exchanges.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Merven Drug shareholders okay pref allotment

Mallya to merge spirits cos, SWC as United Spirits

SWC-Modi issue: High Court stays UB, Jumbo deal

Restructuring to be over in 6 months: Mallya

Ucal Fuel may buy US co

SEBI board meet today to discuss revised corporate governance norms

Eveready to set up battery unit in Uttaranchal

LG's GSM plant begins operations in Pune

Dabur evaluates private label business for toothpastes

JK Industries sees 10% growth in turnover

Bescom hopes to raise revenue by 11 pc

Cash crunch: MFL stops producing complex fertilisers